BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 20197557)

  • 1. Nausea and vomiting in advanced cancer.
    Ang SK; Shoemaker LK; Davis MP
    Am J Hosp Palliat Care; 2010 May; 27(3):219-25. PubMed ID: 20197557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer.
    Mystakidou K; Befon S; Liossi C; Vlachos L
    Cancer; 1998 Sep; 83(6):1214-23. PubMed ID: 9740088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of nausea nad vomiting in palliative medicine].
    Bausewein C
    Z Arztl Fortbild Qualitatssich; 2000 Sep; 94(7):569-73. PubMed ID: 11048341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nausea and vomiting in advanced cancer: the Cleveland Clinic protocol.
    Gupta M; Davis M; LeGrand S; Walsh D; Lagman R
    J Support Oncol; 2013 Mar; 11(1):8-13. PubMed ID: 23137588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M; Chaudhary L; Awan FT; Khan JK; Kojouri K; Ozer H; Tfayli A
    J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.
    Stapleton J; Wo JM
    Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):57-72, vi. PubMed ID: 19232281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroparesis-associated refractory nausea treated with aprepitant.
    Fahler J; Wall GC; Leman BI
    Ann Pharmacother; 2012 Dec; 46(12):e38. PubMed ID: 23191934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens.
    Trigg ME; Inverso DM
    Bone Marrow Transplant; 2008 Oct; 42(8):501-6. PubMed ID: 18724391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tropisetron and chlorpromazine combinations in the control of nausea and vomiting of patients with advanced cancer.
    Mystakidou K; Befon S; Liossi C; Vlachos L
    J Pain Symptom Manage; 1998 Mar; 15(3):176-84. PubMed ID: 9564119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimising antiemetic therapy: what are the problems and how can they be overcome?
    Aapro M
    Curr Med Res Opin; 2005 Jun; 21(6):885-97. PubMed ID: 15969889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J; Trnený M; Procházka B; Klener P
    Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modern aspects of antiemetic therapy].
    Aleksandrović J; Dagović A; Jeremić B
    Srp Arh Celok Lek; 1998; 126(7-8):295-303. PubMed ID: 9863398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New developments in the treatment of nausea and vomiting caused by chemotherapy].
    de Wit R; van Alphen MM
    Ned Tijdschr Geneeskd; 2003 Apr; 147(15):690-4. PubMed ID: 12722531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of dexamethasone with 5-HT3-receptor antagonists for chemotherapy-induced nausea and vomiting.
    Perez EA
    Cancer J Sci Am; 1998; 4(2):72-7. PubMed ID: 9532406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevention and treatment of postoperative nausea and postoperative vomiting with tropisetron].
    Hennes HJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Oct; 32(10):628-31. PubMed ID: 9445562
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding nausea and vomiting in advanced cancer.
    Perdue C
    Nurs Times; 2005 Jan 25-31; 101(4):32-5. PubMed ID: 15719789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.